Mobile technologies are gaining greater acceptance and adoption in clinical trials, to engage patients, investigators, and study team

  • 90% of SMS are opened within 3 minutes

  • 85% of people prefer SMS over email or phone calls

  • 56% of the world population owns a smartphone

Every clinical trial needs a mobile strategy to get to patients, investigators, and study teams.

  • Collect digital endpoint

  • Notify Investigators of AE

  • Upcoming visit notification

  • Improve Medication adherence

  • Study team updates of any serious adverse events

50,000 health apps as of 2020

Virtually everyone has a smartphone these days, which theoretically means that investing in the development of a mobile app is a good idea. However, the problem is that mobile apps aren’t as effective as some of the studies and statistics have led us to believe.

  • 70% of smartphone users spend their time on just the three most frequently used apps.

  • 52% of apps lose half of their peak within three months of launch

SMS gains 98% better response rate over email or mobile app push notification

  • SMS is fast. You can send a message and the recipient will be notified within seconds
  • Apps are notoriously vulnerable to hackers
  • Can get to users wherever they are, using various messaging services

At Delve Health, we utilize various messaging solutions (i.e. SMS, WhatsApp, WeChat) for better global patient, investigator and study team reach.

  • Collect ePRO through SMS to gain up to 95% compliance
  • Deliver visit notifications to help reduce lost to follow-up
  • Notify investigators and study teams of possible adverse events

Delve Health’s Clinical StudyPal is a decentralized platform that can help engage sponsors, investigative sites, and patients to collect the most pertinent information. We help improve patient compliance in clinical trials, create better consent modules, and integrate with EDC/CTMS/eTMF/Wearables for better clinical trial conduct.

Reach out and talk to our experts on how to implement cost-effective ePRO/eDiary and notification solution for your clinical trial



Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle—Not the Other Way Around

A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There
real-time outcomes

Remote Patient Monitoring in Clinical Trials

In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the
Screen Shot Clinical researcher

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The
Patient Reported Outcomes

Conversations On the Ground—Traditional CROs vs. Virtual CROs

Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all
Screen Shot afortiori development

Delve Health and Afortiori Development Announced Their Collaboration. What Does it Mean for Clinical Research?

Delve Health, a clinical research technology firm, and Afortiori Development, a clinical contract research organization (CRO), have announced an exciting partnership to expand patient
clinical trail day screenshot

Clinical Trials Day

May 20, 2022—Today is Clinical Trials Day. A day to recognize and raise awareness as to why clinical trials are so important to all